Lynx1 Capital Management as of Dec. 31, 2022
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 13 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cabaletta Bio (CABA) | 22.6 | $26M | 2.8M | 9.25 | |
| Alpine Immune Sciences (ALPN) | 19.9 | $23M | 3.1M | 7.35 | |
| Merus N V (MRUS) | 11.4 | $13M | 855k | 15.47 | |
| Kinnate Biopharma (KNTE) | 10.5 | $12M | 2.0M | 6.10 | |
| Cymabay Therapeutics | 9.0 | $10M | 1.7M | 6.27 | |
| Bellus Health Com New | 7.8 | $9.0M | 1.1M | 8.22 | |
| Pieris Pharmaceuticals (PIRS) | 5.1 | $5.9M | 5.6M | 1.04 | |
| Pardes Biosciences | 4.4 | $5.1M | 3.0M | 1.69 | |
| Passage Bio (PASG) | 4.0 | $4.6M | 3.4M | 1.38 | |
| Theseus Pharmaceuticals | 3.4 | $3.9M | 784k | 4.98 | |
| Neoleukin Therapeutics | 1.0 | $1.2M | 2.3M | 0.51 | |
| Aadi Bioscience (AADI) | 0.7 | $831k | 65k | 12.83 | |
| Pharvaris N V (PHVS) | 0.2 | $285k | 25k | 11.25 |
